BlackRock Fund Advisors’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$1.9M Buy
399,317
+50,951
+15% +$277K ﹤0.01% 3173
2016
Q3
$2.3M Buy
348,366
+17,358
+5% +$92.4K ﹤0.01% 3128
2016
Q2
$1.81M Buy
331,008
+30,400
+10% +$485K ﹤0.01% 3208
2016
Q1
$6.43M Sell
300,608
-13,215
-4% -$296K ﹤0.01% 2607
2015
Q4
$9.92M Buy
313,823
+14,033
+5% +$496K ﹤0.01% 2451
2015
Q3
$10.3M Buy
299,790
+38,043
+15% +$1.15M ﹤0.01% 2359
2015
Q2
$8.24M Buy
261,747
+20,985
+9% +$618K ﹤0.01% 2618
2015
Q1
$7.06M Buy
240,762
+43,091
+22% +$1.01M ﹤0.01% 2637
2014
Q4
$3.66M Buy
197,671
+28,098
+17% +$474K ﹤0.01% 3022
2014
Q3
$2.97M Sell
169,573
-6,977
-4% -$130K ﹤0.01% 3029
2014
Q2
$3.53M Buy
+176,550
New +$3.41M ﹤0.01% 3016

Other funds holding MRTX